Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Dr. Wallace and Dr. Stone reply.

Wallace ZS, Stone JH.

J Rheumatol. 2013 Jul;40(7):1232. No abstract available.

PMID:
23980261
2.

Treatment of relapsing polychondritis with tocilizumab.

Wendling D, Godfrin-Valnet M, Prati C.

J Rheumatol. 2013 Jul;40(7):1232. doi: 10.3899/jrheum.130371. No abstract available.

PMID:
23818726
3.

Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.

Wallace ZS, Stone JH.

J Rheumatol. 2013 Jan;40(1):100-1. doi: 10.3899/jrheum.120381. No abstract available.

PMID:
23280172
4.

Relapsing polychondritis: response to tocilizumab and association with colitis.

Plunkett M, Lamont D, Brooker J, White D.

J Clin Rheumatol. 2013 Oct;19(7):415-7. doi: 10.1097/RHU.0b013e3182a6fec9. No abstract available.

PMID:
24048111
5.

Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.

Narshi CB, Allard SA.

Rheumatology (Oxford). 2012 May;51(5):952-3. doi: 10.1093/rheumatology/ker451. Epub 2012 Jan 31. No abstract available.

6.

Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.

Terreaux W, Mestrallet S, Fauconier M, Pennaforte JL, Penalba C, Eschard JP, Salmon JH.

Rheumatology (Oxford). 2015 Nov;54(11):2111-3. doi: 10.1093/rheumatology/kev255. Epub 2015 Jul 14. Review. No abstract available.

PMID:
26175469
7.

Sustained remission of pediatric relapsing polychondritis with adalimumab.

Navarrete VM, Lebrón CV, de Miera FJ, Candau CP, Sarabia FN.

J Clin Rheumatol. 2014 Jan;20(1):45-6. doi: 10.1097/RHU.0000000000000063. No abstract available.

PMID:
24356482
8.

Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.

Keidel S, McColl A, Edmonds S.

BMJ Case Rep. 2011 Dec 21;2011. pii: bcr1020114935. doi: 10.1136/bcr.10.2011.4935.

9.

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.

Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, Narazaki M, Ogata A, Kawase I, Kishimoto T, Tanaka T.

Rheumatology (Oxford). 2009 Mar;48(3):318-9. doi: 10.1093/rheumatology/ken468. Epub 2008 Dec 23. No abstract available.

10.

Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.

Nakamura H, Suzuki T, Nagaoka K, Yamasaki S, Tamai M, Hayashi T, Kawakami A.

Mod Rheumatol. 2011 Dec;21(6):665-8. doi: 10.1007/s10165-011-0453-4. Epub 2011 Apr 21.

PMID:
21509650
11.

Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.

Seymour MW, Home DM, Williams RO, Allard SA.

Rheumatology (Oxford). 2007 Nov;46(11):1738-9. Epub 2007 Oct 12. No abstract available.

12.

Tocilizumab for systemic juvenile idiopathic arthritis.

Hagino N, Yamaguchi K, Ohara Y.

N Engl J Med. 2013 Mar 28;368(13):1256. doi: 10.1056/NEJMc1301017#SA1. No abstract available.

PMID:
23534567
13.

Tocilizumab for systemic juvenile idiopathic arthritis.

De Benedetti F.

N Engl J Med. 2013 Mar 28;368(13):1256-7. doi: 10.1056/NEJMc1301017. No abstract available.

14.

Devic disease: translational medicine at work.

Rose-John S, Gold R.

Neurology. 2014 Apr 15;82(15):1294-5. doi: 10.1212/WNL.0000000000000322. Epub 2014 Mar 14. No abstract available.

PMID:
24634457
15.

A new era in the treatment of systemic juvenile idiopathic arthritis.

Sandborg C, Mellins ED.

N Engl J Med. 2012 Dec 20;367(25):2439-40. doi: 10.1056/NEJMe1212640. No abstract available.

PMID:
23252530
16.

Relapsing polychondritis.

Chopra R, Chaudhary N, Kay J.

Rheum Dis Clin North Am. 2013 May;39(2):263-76. doi: 10.1016/j.rdc.2013.03.002. Review.

PMID:
23597963
17.

Interleukin-6 targeting therapy in familial Mediterranean fever.

Fujikawa K, Migita K, Tsukada T, Umeda M, Nonaka F, Kawakami A, Eguchi K.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):150-1. Epub 2013 Sep 9. No abstract available.

PMID:
24064027
18.

The interleukin 6 pathway and atherosclerosis.

Scheller J, Rose-John S.

Lancet. 2012 Jul 28;380(9839):338. doi: 10.1016/S0140-6736(12)61246-X. No abstract available.

PMID:
22841333
19.

The interleukin-6 pathway and atherosclerosis.

Boekholdt SM, Stroes ES.

Lancet. 2012 Mar 31;379(9822):1176-8. doi: 10.1016/S0140-6736(12)60361-4. Epub 2012 Mar 14. No abstract available.

PMID:
22421338
20.

Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases.

Diamantopoulos AP, Hatemi G.

Rheumatology (Oxford). 2013 Oct;52(10):1923-4. doi: 10.1093/rheumatology/ket130. Epub 2013 Apr 4. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk